NCT03561025View on ClinicalTrials.gov

Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
SarcoidosisCardiomyopathies
Interventions
DIAGNOSTIC_TEST

18F-FDG-PET/MRI

Contrast-enhanced MRI scanning after injection of 18F-FDG

DIAGNOSTIC_TEST

18F-GE180-PET/MRI

Contrast-enhanced MRI scanning after injection of 18F-GE180

Trial Locations (1)

Unknown

St Olav University Hospital, Dept Radiology and Nuclear Medicine, Trondheim

All Listed Sponsors
collaborator

Norwegian University of Science and Technology

OTHER

collaborator

University Hospital, Essen

OTHER

lead

St. Olavs Hospital

OTHER

NCT03561025 - Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis | Biotech Hunter | Biotech Hunter